Synthesis, Structural, DFT, In Vitro Biological Exploration, and DNA Interaction of New Ni(II) and Cu(II) Mixed‐Ligand Complexes Featuring 2,2′‐Pyridine‐2,6‐diylbis(1H‐benzimidazole) and 2‐Hydroxy‐naphthaldehyde‐Based Schiff‐Base

Ejemplares similares

• Two Octahedral Ni(II) and Cu(II) Mixed‐Ligand Complexes Incorporating 2,6‐Di(1H‐Pyrazol‐1‐yl)Pyridine and 4,4′‐Bipyridine: Synthesis, Characterization, In Vitro Bioactivity, and Molecular Docking Exploration
  por: Mai M. Khalaf, et al.
  Publicado: (2024)
• Synthesis and Characterization of Octahedral Ni(II) and Cu(II) Complexes With Imidazole‐Based Ligands: Structural, DFT, and Molecular Docking, Enhanced Antimicrobial, and Anti‐Inflammatory Activity
  por: Aly Abdou, et al.
  Publicado: (2025)
• Synthesis, structural, biological applications, DFT, molecular docking studies on Fe(III), Co(II), and Ni(II) complexes incorporating 2‐(pyridin‐2‐yl)phenol and 1H‐benzimidazole‐2‐carboxylic acid
  por: Mai M. Khalaf, et al.
  Publicado: (2024)
• Green Synthesis of New Water‐Soluble Nickel (II) and Copper (II) Mixed‐Ligand Complexes: Characterization, DFT, In Vitro Biological Evaluation, and COVID‐19 Molecular Docking
  por: Mai M. Khalaf, et al.
  Publicado: (2025)
• Synthesis, Characterization, and Therapeutic Potential of Novel Schiff Base Metal Complexes: Nickel(II) and Copper(II) Complexes Based 2‐[(2‐Chloroquinolin‐3‐yl)methylidene]aminobenzenethiol (CQAT)
  por: Hany M. Abd El‐Lateef, et al.
  Publicado: (2024)